SCHEMBL3240150

SCHEMBL3240150

[CH2]c1ccc(CN(C)Cc2ccc(F)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PYCR1 P32322 3/20 0.56
TAAR1 Q96RJ0 1/20 0.45
NPC1 O15118 1/20 0.44
CXCR3 P49682 1/20 0.44
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
AOC3 Q16853 1/20 0.42
KMT2A Q03164 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
RIPK1 Q13546 1/20 0.41
MEN1 O00255 2/20 0.41
RAB9A P51151 1/20 0.41
LMNA P02545 1/20 0.40
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
DAO P14920 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3191532 0.89 PYCR1 (0.67) PYCR1TAAR1NPC1CXCR3ALDH1A1
SCHEMBL22304838 0.83 PYCR1 (0.60) PYCR1TAAR1NPC1CXCR3ALDH1A1
SCHEMBL3240218 0.81 HTT (0.44) PYCR1ALDH1A1KDM4ESMN1; SMN2KMT2A
SCHEMBL13232509 0.81 PYCR1 (0.58) PYCR1TAAR1NPC1CXCR3ALDH1A1
SCHEMBL3242409 0.81 ALDH1A1 (0.54) PYCR1TAAR1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL3339451 0.81 PYCR1 (0.58) PYCR1TAAR1NPC1CXCR3ALDH1A1
SCHEMBL21268450 0.81 ALDH1A1 (0.63) PYCR1NPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL3153174 0.79 PYCR1 (0.56) PYCR1TAAR1NPC1CXCR3ALDH1A1
SCHEMBL171946 0.78 PYCR1 (0.60) PYCR1TAAR1NPC1CXCR3ALDH1A1
Hydrochloric Acid SCHEMBL27258921 0.77 PYCR1 (0.58) PYCR1TAAR1NPC1CXCR3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100144733-A1 Compounds, compositions and methods comprising heteroaromatic derivatives INSTITUTE FOR ONEWORLD HEALTH 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144733-A1 Compounds, compositions and methods comprising heteroaromatic derivatives CFTR, PKD1, PKD2 PYCR1 95/4885TAAR1 2698/4885NPC1 233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.